FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017966192> ?p ?o ?g. }

• W2017966192 endingPage "596" @default.
• W2017966192 startingPage "589" @default.
• W2017966192 abstract "Objective To obtain further insight into the mechanism underlying the vasodilator effect of nebivolol. Since oxidative inactivation of nitric oxide (NO) is regarded as an important cause of its decreased biological activity, we studied (1) the effect of nebivolol on some oxidative parameters in essential hypertensive patients; (2) the effect of plasma of nebivolol-treated patients on reactive oxygen species production and NO availability in endothelial cells. Methods A total of 20 healthy subjects and 20 matched essential hypertensive patients treated with atenolol or nebivolol according to a double-blind, randomized design participated in the study. We measured low-density lipoprotein (LDL) and plasma hydroperoxides, 8-isoprostanes, oxidized LDL, susceptibility of LDL to oxidation (lag phase) and LDL vitamin E and the effect of plasma of nebivolol- and atenolol-treated patients on reactive oxygen species production and NO availability in endothelial cells exposed to oxidative stress. Results In hypertensive patients, nebivolol and atenolol significantly reduced blood pressure values after 4 weeks of treatment. Plasma and LDL hydroperoxides, plasma 8-isoprostanes, plasma ox-LDL and LDL lag phase were significantly improved only in the patients receiving nebivolol compared with the atenolol group. Similarly there was a reduction of reactive oxygen species (ROS) and O2•− concentration in endothelial cells exposed to oxidative stress after incubation of the cells with plasma of the patients enrolled in the trial only in the patients receiving nebivolol compared to atenolol group. Furthermore, the reduction of basal and stimulated NO induced by oxidative stress in endothelial cells was significantly lower in the patients receiving nebivolol compared to atenolol group. Conclusions The findings of the present study indicate that nebivolol, through its antioxidant properties, increases NO also by decreasing its oxidative inactivation." @default.
• W2017966192 created "2016-06-24" @default.
• W2017966192 creator A5013936744 @default.
• W2017966192 creator A5020180732 @default.
• W2017966192 creator A5032520583 @default.
• W2017966192 creator A5044719023 @default.
• W2017966192 creator A5052444609 @default.
• W2017966192 creator A5065323100 @default.
• W2017966192 creator A5071020925 @default.
• W2017966192 creator A5086857657 @default.
• W2017966192 date "2005-03-01" @default.
• W2017966192 modified "2023-10-16" @default.
• W2017966192 title "Nebivolol decreases oxidative stress in essential hypertensive patients and increases nitric oxide by reducing its oxidative inactivation" @default.
• W2017966192 cites W1520014993 @default.
• W2017966192 cites W1754453110 @default.
• W2017966192 cites W1940436875 @default.
• W2017966192 cites W1972938168 @default.
• W2017966192 cites W1973223262 @default.
• W2017966192 cites W1975465206 @default.
• W2017966192 cites W1992718978 @default.
• W2017966192 cites W1994916925 @default.
• W2017966192 cites W2007375934 @default.
• W2017966192 cites W2007996849 @default.
• W2017966192 cites W2009622577 @default.
• W2017966192 cites W2013545198 @default.
• W2017966192 cites W2013557200 @default.
• W2017966192 cites W2044267632 @default.
• W2017966192 cites W2050548878 @default.
• W2017966192 cites W2050814649 @default.
• W2017966192 cites W2064484362 @default.
• W2017966192 cites W2071022372 @default.
• W2017966192 cites W2084581577 @default.
• W2017966192 cites W2100249758 @default.
• W2017966192 cites W2108385540 @default.
• W2017966192 cites W2121527030 @default.
• W2017966192 cites W2122115743 @default.
• W2017966192 cites W2133150758 @default.
• W2017966192 cites W2135503869 @default.
• W2017966192 cites W2135633069 @default.
• W2017966192 cites W2145899271 @default.
• W2017966192 cites W2153491246 @default.
• W2017966192 cites W2154831591 @default.
• W2017966192 cites W2164382299 @default.
• W2017966192 cites W2169182236 @default.
• W2017966192 cites W2170457471 @default.
• W2017966192 cites W2189057339 @default.
• W2017966192 cites W2327589969 @default.
• W2017966192 cites W2328103583 @default.
• W2017966192 cites W4254181710 @default.
• W2017966192 cites W4302577822 @default.
• W2017966192 doi "https://doi.org/10.1097/01.hjh.0000160216.86597.ff" @default.
• W2017966192 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15716701" @default.
• W2017966192 hasPublicationYear "2005" @default.
• W2017966192 type Work @default.
• W2017966192 sameAs 2017966192 @default.
• W2017966192 citedByCount "108" @default.
• W2017966192 countsByYear W20179661922012 @default.
• W2017966192 countsByYear W20179661922013 @default.
• W2017966192 countsByYear W20179661922014 @default.
• W2017966192 countsByYear W20179661922015 @default.
• W2017966192 countsByYear W20179661922016 @default.
• W2017966192 countsByYear W20179661922017 @default.
• W2017966192 countsByYear W20179661922018 @default.
• W2017966192 countsByYear W20179661922019 @default.
• W2017966192 countsByYear W20179661922020 @default.
• W2017966192 countsByYear W20179661922021 @default.
• W2017966192 countsByYear W20179661922022 @default.
• W2017966192 countsByYear W20179661922023 @default.
• W2017966192 crossrefType "journal-article" @default.
• W2017966192 hasAuthorship W2017966192A5013936744 @default.
• W2017966192 hasAuthorship W2017966192A5020180732 @default.
• W2017966192 hasAuthorship W2017966192A5032520583 @default.
• W2017966192 hasAuthorship W2017966192A5044719023 @default.
• W2017966192 hasAuthorship W2017966192A5052444609 @default.
• W2017966192 hasAuthorship W2017966192A5065323100 @default.
• W2017966192 hasAuthorship W2017966192A5071020925 @default.
• W2017966192 hasAuthorship W2017966192A5086857657 @default.
• W2017966192 hasConcept C126322002 @default.
• W2017966192 hasConcept C134018914 @default.
• W2017966192 hasConcept C185592680 @default.
• W2017966192 hasConcept C2776151105 @default.
• W2017966192 hasConcept C2776525901 @default.
• W2017966192 hasConcept C2777097880 @default.
• W2017966192 hasConcept C2777537511 @default.
• W2017966192 hasConcept C2780972559 @default.
• W2017966192 hasConcept C48349386 @default.
• W2017966192 hasConcept C519581460 @default.
• W2017966192 hasConcept C55493867 @default.
• W2017966192 hasConcept C71924100 @default.
• W2017966192 hasConcept C84393581 @default.
• W2017966192 hasConcept C98274493 @default.
• W2017966192 hasConceptScore W2017966192C126322002 @default.
• W2017966192 hasConceptScore W2017966192C134018914 @default.
• W2017966192 hasConceptScore W2017966192C185592680 @default.
• W2017966192 hasConceptScore W2017966192C2776151105 @default.
• W2017966192 hasConceptScore W2017966192C2776525901 @default.
• W2017966192 hasConceptScore W2017966192C2777097880 @default.
• W2017966192 hasConceptScore W2017966192C2777537511 @default.

• next